ANNOUNCEMENT

These 11 companies will be featured in the MedCity ENGAGE Innovation Showcase June 5-6 in Washington, D.C.

Topic: Molecular Targeting Technologies

Biotechnology firm acquires imaging technology license to improve acute coronary syndrome diagnosis

Biotechnology firm acquires imaging technology license to improve acute coronary syndrome diagnosis

August 1, 2012 8:41 pm by | 0 Comments

A biotechnology company’s licensing deal for a radiopharmaceutical could make it easier to diagnoseacute coronary syndrome in cases that might otherwise go undiagnosed or be diagnosed too late.Molecular Targeting Technologies ... Read more